Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, dal 1982 In collaborazione con l'Associazione Culturale Pediatri

Il punto su

PDF MeBrain

Uso di Cannabis in gravidanza: esiti a breve e lungo termine nella prole

Use of Cannabis in pregnancy: short- and long-term outcomes in offspring

Veronica Notarbartolo1, Calogero Fabio Giardina2, Antonina Lo Cascio3
1Scuola di Specializzazione in Pediatria, Dipartimento per la Promozione della Salute, Materno-Infantile, di Medicina Interna e di Eccellenza Specialistica “G. D’Alessandro”, Università di Palermo
2Unità di Terapia Intensiva Neonatale e Neonatologia, PO V. Cervello, Palermo
3Pediatra di famiglia, ASP 6, Palermo; docente di Pediatria e Cure Primarie, Scuola di Specializzazione in Pediatria, Università di Palermo

Febbraio 2022 | DOI: 10.53126/MEBXXV049

Abstract
Cannabis is the most consumed drug in Europe, especially among adolescents. In the last few years, several studies have demonstrated that its use has increased in pregnancy and this could be a risk factor for the onset of neurodevelopmental disorders in offspring. Moreover, it is well known that low birth weight and preterm labour are associated with Cannabis use in pregnancy. The article presents the case of a newborn who was small for gestational age, presented with a meconium aspiration syndrome and acute neurologic signs and whose mother used Cannabis during pregnancy.
Riassunto
La Cannabis è la droga più consumata in Europa, soprattutto tra gli adolescenti. Negli ultimi anni, diversi studi hanno dimostrato che anche in gravidanza il suo utilizzo è in aumento e questo può essere un fattore di rischio per l’insorgenza di disturbi del neurosviluppo nella prole, pur non essendo gli studi conclusivi. Al contrario, è ben noto come il basso peso alla nascita e il parto pretermine siano associati all’uso di Cannabis in gravidanza. Presentiamo il caso clinico di un neonato, piccolo per età gestazionale, con una sindrome da aspirazione di meconio e segni neurologici acuti, la cui madre ha fatto uso di Cannabis durante la gestazione.
Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Per l'acquisto del singolo articolo scrivi a abbonamenti@medicoebambino.com (la mail si prepara da sola con gli estremi dell'articolo); se accedi, la richiesta parte con un click.

Bibliografia

  1. Chiossi M, Di Pietro P. Tossicologia pediatrica. Masterbooks, 2019. ISBN 9788867610303.
  2. Serpelloni G (ed). Cannabis e danni alla salute. Dipartimento Politiche Antidroga, 2010.
  3. Brown SJ, Mensah FK, Kit JA, et al. Use of Cannabis during pregnancy and birth outcomes in an Aboriginal birth cohort: a cross-sectional, population-based study. BMJ Open 2016;6(2):e010286. doi: 10.1136/bmjopen-2015-010286.
  4. Badowski S, Smith G. Cannabis use during pregnancy and postpartum. Can Fam Physician 2020;66(2):98-103.
  5. Grzeskowiak LE, Grieger JA, Andraweera P, et al. The deleterious effects of Cannabis during pregnancy on neonatal outcomes. Med J Aust 2020;212(11):519-24. doi: 10.5694/mja2.50624.
  6. Jaques SC, Kingsbury A, Henshcke P, et al. Cannabis, the pregnant woman and her child: weeding out the myths. Journal of Perinatology (2014) 34, 417-24. doi: 10.1038/jp.2013.180.
  7. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The health effects of Cannabis and cannabinoids. The current state of evidence and recommendations for research. Washington (DC): National Academies Press (US), 2017. ISBN-13: 978-0-309-45304-2.
  8. Warner TD, Roussos-Ross D, Behnke M. It’s not your mother’s marijuana: effects on maternal-fetal health and the developing child. Clin Perinatol 2014;41(4):877-94. doi: 10.1016/j.clp.2014.08.009.
  9. Baker T, Datta P, Rewers-Felkins K, Thompson H, Kallem RR, Hale TW. Transfer of inhaled Cannabis into human breast milk. Obstet Gynecol 2018;131(5):783-8. doi: 10.1097/AOG.0000000000002575.
  10. Navarrete F, Garcia-Gutièrrez MS, Gasparyan A, Austrich-Olivares A, Femenia T, Manzanares J. Cannabis use in pregnant and breastfeeding women: behavioral and neurobiological consequences. 2020;11:586447. doi: 10.3389/fpsyt.2020.586447.
  11. Gunn JKL, Rosales CB, Center KE, et al. Prenatal exposure to Cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016;6:e009986. doi: 10.1136/bmjopen-2015-009986.
  12. Lubman DI, Cheetham A, Yücel M. Cannabis and adolescent brain development. Pharmacol Ther 2015;148:1-16. doi: 10.1016/j.pharmthera.2014.11.009.
  13. Skosnik PD, Cortes-Briones JA. Electroencephalography and Cannabis: from event-related potentials to oscillations. In: Preedy V (ed). Neuropathology of drug addictions and substance misuse. Vol 1, Chap 80. Elsevier, 2016. ISBN: 9780128002131.
  14. Carvalho A, Evans-Gilbert T. The pathophysiology of marijuana-induced encephalopathy and possible epilepsy after ingestion in children: a case series. Innov Clin Neurosci 2019;16(3-4):16-8.
  15. Halloran D. Community Paediatric Review: a National Publication for Community Child Health Nurses and Other Professionals. Use of Cannabis in pregnancy and as a new parent. Royal Children’s Hospital, Melbourne, 2010.
  16. Roncero C, Valriberas-Herrero I, Mezzatesta-Gava M, Villegas JL, Aguilar L, Grau-Lòpez L. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. Reprod Health 2020;17(1):25. doi: 10.1186/s12978-020-0880-9.
  17. Australian NSW Department of Health. The National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn. 2006.
  18. Amirav I, Luder A, Viner Y, Finkel M. Decriminalization of Cannabis-potential risks for children? Acta Paediatr 2011;100(4):618-9. doi: 10.1111/j.1651-2227.2010.02081.x.
  19. Whitehill JM, Harrington C, Lang CJ, Chary M, Bhutta WA, Burns MM. Incidence of pediatric Cannabis exposure among children and teenagers aged 0 to 19 years before and after medical marijuana legalization in Massachusetts. JAMA Network Open 2019;2(8):e199456. doi: 10.1001/jamanetworkopen.2019.9456.
  20. Jansson LM, Patrick SW. Neonatal abstinence syndrome. Pediatr Clin North Am 2019;66(2):353-67. doi: 10.1016/j.pcl.2018.12.006.